Preclinical Pharmacology of OPC-34712: A Novel Compound with Dopamine D2 Receptor Partial Agonist Activity

被引：0
|
作者：
Kikuchi, Tetsuro [1 ]
Maeda, Kenji [1 ]
Sugino, Haruhiko [1 ]
Akazawa, Hitomi [1 ]
Amada, Naoki [1 ]
Jordan, Shaun [2 ]
Shimada, Jun [1 ]
Yamashita, Hiroshi [1 ]
Ito, Nobuaki [1 ]
Forbes, Robert A. [3 ]
McQuade, Robert D. [3 ]
机构：
[1] Otsuka Pharmaceut Co Ltd, Quest Res Inst, Tokushima 77101, Japan
[2] Otsuka Pharmaceut Co Ltd, Otsuka Maryland Med Labs Inc, Rockville, MD USA
[3] Otsuka Pharmaceut Co Ltd, Otsuka Pharmaceut Dev & Commercializat, Princeton, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2011年 / 69卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
320
引用
收藏
页码：95S / 95S
页数：1
相关论文
共 50 条
  • [21] Discovery of a true bivalent dopamine D2 receptor agonist
    Qian, Mingcheng
    Ricarte, Adrian
    Wouters, Elise
    Dalton, James A. R.
    Risseeuw, Martijn D. P.
    Giraldo, Jesus
    Van Calenbergh, Serge
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
  • [22] VANADATE INHIBITS AGONIST BINDING TO D2 DOPAMINE RECEPTOR
    ELAZAR, Z
    FUCHS, S
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 1991, 3 (01) : 1 - 6
  • [23] Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist
    Xu, Jinbin
    Vangveravong, Suwanna
    Li, Shihong
    Fan, Jinda
    Jones, Lynne A.
    Cui, Jinquan
    Wang, Ruike
    Tu, Zhude
    Chu, Wenhua
    Perlmutter, Joel S.
    Mach, Robert H.
    [J]. NEUROIMAGE, 2013, 71 : 168 - 174
  • [24] TERGURIDE, A DOPAMINE D2 PARTIAL AGONIST, AS A DISCRIMINATIVE STIMULUS IN RATS
    YAMAGUCHI, M
    KIMURAIWASAKI, K
    AKAI, T
    NAKADA, Y
    NAKAGAWA, H
    [J]. BEHAVIOURAL PHARMACOLOGY, 1991, 2 (03): : 233 - 240
  • [25] The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa
    Frank, Guido K. W.
    Shott, Megan E.
    Hagman, Jennifer O.
    Schiel, Marissa A.
    DeGuzman, Marisa C.
    Rossi, Brogan
    [J]. INTERNATIONAL JOURNAL OF EATING DISORDERS, 2017, 50 (04) : 447 - 450
  • [26] BREXPIPRAZOLE: A NEW DOPAMINE D2 RECEPTOR PARTIAL AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA AND MAJOR DEPRESSIVE DISORDER
    Citrome, L.
    [J]. DRUGS OF TODAY, 2015, 51 (07) : 397 - 414
  • [27] Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist
    Heinrich, Julia N.
    Brennan, Julie
    Lai, Margaret H.
    Sullivan, Kelly
    Hornby, Geoff
    Popiolek, Mike
    Jiang, Li-Xin
    Pausch, Mark H.
    Stack, Gary
    Marquis, Karen L.
    Andree, Terrance H.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 552 (1-3) : 36 - 45
  • [28] Assays for enhanced activity of low efficacy partial agonists at the D2 dopamine receptor
    Lin, H.
    Saisch, S. G. N.
    Strange, P. G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (03) : 291 - 299
  • [29] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    [J]. Psychopharmacology, 2014, 231 : 613 - 619
  • [30] Pharmacological profile of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist atypical antipsychotic
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszlovszky, I.
    Horvath, A.
    Laszy, J.
    Schmidt, E.
    Szabo, G.
    Domany, G.
    Csongor, E. Agai
    Tihanyi, K.
    Szombathelyi, Z.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S432 - S432
12345